Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05816915 Sponsor: General University Hospital, Prague Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT05816915
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with non-alcoholic fatty liver disease (a condition where excess fat builds up in the liver not caused by alcohol) and metabolic syndrome (a group of conditions including high blood pressure, high blood sugar, and excess body fat around the waist)

Who may not be able to join:

  • Your liver disease is caused by something other than non-alcoholic fatty liver disease (such as alcohol or another condition)
  • You have been diagnosed with any form of cancer or malignant disease
  • You have a heart or cardiovascular condition that is not well managed or controlled
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Radan Bruha, Prof., General University Hospital, Prague

Phone: +420224962506

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
General University Hospital, Prague
Registry
ClinicalTrials.gov
Start date
30 August 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

The effect of CBT on liver fat content; The effect of CBT on inflammatory parameters; The effect of CBT on liver fibrosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov